IDEAS home Printed from https://ideas.repec.org/p/ohe/briefg/002146.html
   My bibliography  Save this paper

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Author

Abstract

The measurement of quality of life in the context of spinal muscular atrophy (SMA) is challenging. This is because the disease is experienced by children and is rare, which makes data collection difficult. This Briefing reports on a symposium that outlined some lessons that can be learnt from the SMA context that might be more widely applicable. Where evidence is lacking for new treatments, because of practical or methodological difficulties, there is a risk that patients remain unable to access cost-effective care. We identify a variety of ways in which current approaches to the measurement of quality of life in SMA may be inadequate. For example, it is unlikely that existing measures of health-related quality of life capture all that is important to patients and caregivers. Based on the discussion, we highlight four possible strategies for improving the quantity and quality of data available to inform decisionmakers in the context of rare diseases - - Bespoke data collection which is relevant to HTA decisionmakers; - Simple economic modelling methods, which reflect the evidence available at thetime of the assessment; - Collaboration among the different parties involved; and - Identifying what is 'good enough' to inform decisionmaking on use at the time oflaunch or of the health technology assessment process. New approaches to research could facilitate health technology assessment processes and improve patients' access to cost-effective treatments for rare diseases.

Suggested Citation

  • Sampson, C. & Garau, M., 2019. "How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy," Briefings 002146, Office of Health Economics.
  • Handle: RePEc:ohe:briefg:002146
    as

    Download full text from publisher

    File URL: https://www.ohe.org/system/files/private/publications/OHE%20Briefing%20-%20How%20Should%20We%20Measure%20Quality%20of%20Life%20Impact%20in%20Rare%20Disease_finalv2.pdf
    Download Restriction: no

    References listed on IDEAS

    as
    1. John Brazier & Yaling Yang & Aki Tsuchiya & Donna Rowen, 2010. "A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(2), pages 215-225, April.
    2. Julio López-Bastida & Juan Oliva-Moreno & Renata Linertová & Pedro Serrano-Aguilar, 2016. "Social/economic costs and health-related quality of life in patients with rare diseases in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 1-5, April.
    3. Kamran Khan & Stavros Petrou & Oliver Rivero-Arias & Stephen Walters & Spencer Boyle, 2014. "Mapping EQ-5D Utility Scores from the PedsQL™ Generic Core Scales," PharmacoEconomics, Springer, vol. 32(7), pages 693-706, July.
    4. Julie Ratcliffe & Elisabeth Huynh & Katherine Stevens & John Brazier & Michael Sawyer & Terry Flynn, 2016. "Nothing About Us Without Us? A Comparison of Adolescent and Adult Health‐State Values for the Child Health Utility‐9D Using Profile Case Best–Worst Scaling," Health Economics, John Wiley & Sons, Ltd., vol. 25(4), pages 486-496, April.
    Full references (including those not matched with items on IDEAS)

    More about this item

    Keywords

    Measuring and valuing outcomes;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:briefg:002146. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Publications Manager). General contact details of provider: http://edirc.repec.org/data/ohecouk.html .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.